Literature DB >> 26697455

Applications of iPSC-derived models of Gaucher disease.

Daniel K Borger1, Elma Aflaki1, Ellen Sidransky1.   

Abstract

Entities:  

Year:  2015        PMID： 26697455      PMCID： PMC4671880          DOI： 10.3978/j.issn.2305-5839.2015.10.41

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  16 in total

1.  iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.

Authors:  Chris M Woodard; Brian A Campos; Sheng-Han Kuo; Melissa J Nirenberg; Michael W Nestor; Matthew Zimmer; Eugene V Mosharov; David Sulzer; Hongyan Zhou; Daniel Paull; Lorraine Clark; Eric E Schadt; Sergio Pablo Sardi; Lee Rubin; Kevin Eggan; Mathew Brock; Scott Lipnick; Mahendra Rao; Stephen Chang; Aiqun Li; Scott A Noggle
Journal:  Cell Rep       Date:  2014-11-06       Impact factor: 9.423

2.  Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.

Authors:  Judi A Sgambato; Tea Soon Park; Diana Miller; Leelamma M Panicker; Ellen Sidransky; Yu Lun; Ola Awad; Søren M Bentzen; Elias T Zambidis; Ricardo A Feldman
Journal:  Stem Cells Transl Med       Date:  2015-06-10       Impact factor: 6.940

3.  Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.

Authors:  Joseph R Mazzulli; You-Hai Xu; Ying Sun; Adam L Knight; Pamela J McLean; Guy A Caldwell; Ellen Sidransky; Gregory A Grabowski; Dimitri Krainc
Journal:  Cell       Date:  2011-06-23       Impact factor: 41.582

4.  Reply: Lysosomal dysfunction in Parkinson's disease.

Authors:  Glenda M Halliday; Karen E Murphy
Journal:  Brain       Date:  2014-09-11       Impact factor: 13.501

5.  Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Authors:  Roy N Alcalay; Tama Dinur; Timothy Quinn; Karina Sakanaka; Oren Levy; Cheryl Waters; Stanley Fahn; Tsvyatko Dorovski; Wendy K Chung; Michael Pauciulo; William Nichols; Huma Q Rana; Manisha Balwani; Louise Bier; Deborah Elstein; Ari Zimran
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 6.  Autosomal recessive mutations in the development of Parkinson's disease.

Authors:  Grisel Lopez; Ellen Sidransky
Journal:  Biomark Med       Date:  2010-10       Impact factor: 2.851

Review 7.  Gaucher disease: complexity in a "simple" disorder.

Authors:  Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

8.  Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

Authors:  Karen E Murphy; Amanda M Gysbers; Sarah K Abbott; Nahid Tayebi; Woojin S Kim; Ellen Sidransky; Antony Cooper; Brett Garner; Glenda M Halliday
Journal:  Brain       Date:  2014-01-28       Impact factor: 13.501

Review 9.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

10.  Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.

Authors:  Matthew E Gegg; Derek Burke; Simon J R Heales; J Mark Cooper; John Hardy; Nicholas W Wood; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422
View more
  2 in total

Review 1.  Lysosomal storage diseases.

Authors:  Frances M Platt; Alessandra d'Azzo; Beverly L Davidson; Elizabeth F Neufeld; Cynthia J Tifft
Journal:  Nat Rev Dis Primers       Date:  2018-10-01       Impact factor: 52.329

2.  CRISPR/Cas9 Editing for Gaucher Disease Modelling.

Authors:  Eleonora Pavan; Maximiliano Ormazabal; Paolo Peruzzo; Emilio Vaena; Paula Rozenfeld; Andrea Dardis
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.